TEGAFIRI is an effective alternative regimen for the management of recurrent or metastatic colorectal cancer

At present, the global incidence of colorectal cancer is increasing, with numerous individuals succumbing to the disease. The standard treatment strategy for colorectal cancer is curative resection. However, a cure is rarely achieved for metastatic colorectal cancer. Currently, chemotherapy is the m...

Descripción completa

Detalles Bibliográficos
Autor principal: HSU, TZU-CHI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314973/
https://www.ncbi.nlm.nih.gov/pubmed/25663857
http://dx.doi.org/10.3892/ol.2015.2855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314973/
https://www.ncbi.nlm.nih.gov/pubmed/25663857
http://dx.doi.org/10.3892/ol.2015.2855

Ejemplares similares